image
Sangamo Therapeutics, Inc. SGMO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.05
-4.65 %
$ 428 M
Market Cap
-1.68
P/E
BALANCE SHEET
165 M ASSETS
-70.61%
Growth Rates
1Year -70.61%
3Years -43.94%
5Years -22.48%
7Years 0.66%
10Years 1.62%
82.4 M LIABILITIES
-69.19%
Growth Rates
1Year -69.19%
3Years -42.83%
5Years -18.11%
7Years 21.01%
10Years 15.73%
82.9 M EQUITY
-71.90%
Growth Rates
1Year -71.90%
3Years -44.97%
5Years -25.72%
7Years -6.85%
10Years -3.77%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Sangamo Therapeutics, Inc.
image
Current Assets 94.3 M
Cash & Short-Term Investments 81 M
Receivables 1.33 M
Other Current Assets 12 M
Non-Current Assets 71 M
Long-Term Investments 0
PP&E 52.9 M
Other Non-Current Assets 18.1 M
Current Liabilities 47.7 M
Accounts Payable 15.3 M
Short-Term Debt 4.59 M
Other Current Liabilities 27.9 M
Non-Current Liabilities 34.7 M
Long-Term Debt 33.5 M
Other Non-Current Liabilities 1.19 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
ASSETS
Cash & Cash Equivalents 45.2 100.4 178.9 131.3 80.4 140.4 49.8 22.1 69.5 6.0 10.2 21.7 16.8 10.8 21.2 19.4 12.3 12.7 18.5 8.6 9.8 17.6 7.6 10.2 0.3 0 0 0
Short Term Investments 35.8 177.2 197.7 510.1 282.0 259.7 193.5 120.5 139.5 172.9 82.6 41.9 67.4 49.5 63.8 45.4 68.8 41.2 28.4 24.6 34.1 34.5 54.0 53.4 7.3 0 0 0
Receivables 1.3 4.5 6.4 6.3 37.6 5.0 3.6 5.2 2.8 10.8 3.5 4.3 1.2 0.7 0.4 0.7 0.5 0.5 1.2 0.8 1.1 1.5 1.7 2.7 0.6 0 0 0
Inventory 0 1 (88.2) (50.5) (22.5) (0.4) (1.3) (0.2) (0.3) (46.7) (38.2) (12.5) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 12.0 36.4 31.7 24.0 10.8 10.7 3.0 1.8 0.8 1.1 1.0 0.5 0.3 0.3 0.4 0.3 0.5 0.6 0.3 0.3 0.3 0.4 0.4 0.3 0 0 0 0
Total Current Assets 94.3 300.3 398.8 659.7 405.5 410.5 248.4 149.6 212.6 190.9 97.3 68.4 85.7 61.3 85.8 65.9 82.1 55.1 48.5 34.4 45.3 54.1 63.8 66.5 8.2 0 0 0
PP&E 52.9 125.5 124.7 112.4 107.2 78.7 31.1 6.6 2.9 1.5 1.4 1.5 1.6 1.7 1.7 2.0 1.8 0.7 0.5 0.3 0.9 1.8 2.8 2.0 0.6 0 0 0
Intangible Assets 0 50.7 53.8 58.1 53.2 54.9 0 0 1.6 1.9 1.9 0 0 0 0 0 0 0 0 0 0 0 18.4 0 0 0 0 0
Goodwill 0 37.6 39.7 42.8 39.3 40.0 1.6 1.6 1.6 1.6 1.6 0 0 0 0 0 0 0 0 0 0 0 15.2 0 0 0 0 0
Long Term Investments 0 29.8 88.2 50.5 21.8 (6.7) 1.0 0 0 47.3 38.7 12.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 18.1 12.3 10.2 7.9 4.0 6.2 4.7 0.2 0.2 0.1 40 K 41 K 41 K 12 K 12 K 12 K 12 K 49 K 49 K 31 K 41 K 0.3 78 K 0.4 0.4 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.0 6.9 0.5
Total Assets 165.3 562.5 721.9 938.5 637.5 590.4 286.7 157.9 217.2 243.2 140.8 82.5 87.3 63.0 87.4 67.8 83.9 55.8 49.0 34.7 46.2 56.2 85.0 68.9 9.2 4.0 6.9 0.5
LIABILITIES
Accounts Payable 15.3 22.4 9.8 12.6 6.7 3.4 16 K 2.6 3.9 5.5 3.0 3.0 4.1 3.5 0 1.7 1.6 1.1 0.8 0.4 0.8 0.9 1.3 0.6 0.3 0 0 0
Short Term Debt 4.6 4.1 4.0 3.7 3.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0
Other Current Liabilities 27.9 33.4 28.4 127.3 21.3 27.6 16.5 6.6 7.1 6.3 4.8 3.4 3.1 3.3 3.8 2.5 3.2 1.5 1.7 1.2 (0.8) (0.9) (1.5) 1.4 0.7 0 0 0
Total Current Liabilities 47.7 111.7 127.9 143.5 69.9 78.5 44.9 13.3 20.1 20.9 10.1 8.8 7.2 7.1 15.7 11.6 9.7 5.2 6.8 2.3 1.6 2.0 2.7 2.0 1.0 0 0 0
Long Term Debt 33.5 39.0 44.1 38.4 41.2 27.7 24.7 3.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0
Deferred Tax Income 0 6.3 6.6 7.2 6.6 6.7 (24.7) (3.9) 0 0.7 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 1.2 1.2 1.2 7.0 5.7 2.0 0 0 0 1.8 1.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Liabilities 82.4 267.6 346.6 441.2 204.8 223.9 98.8 21.7 24.8 36.6 19.1 17.6 7.2 7.1 15.7 12.5 11.8 7.1 11.2 2.3 1.6 2.0 2.7 2.0 1.3 0.6 0.5 0.1
EQUITY
Common Stock 1.8 1.7 1.5 1.4 1.2 1.0 0.9 0.7 0.7 0.7 0.6 0.5 0.5 0.5 0.5 0.4 0.4 0.3 148.2 129.5 127.9 127.2 127.2 89.8 3.3 0 0 0
Retained Earnings (1 406.4) (1 148.5) (956.3) (778.0) (657.0) (562.7) (495.5) (440.9) (369.3) (328.6) (302.1) (275.5) (253.2) (217.5) (192.6) (174.1) (149.8) (128.3) (110.4) (97.1) (83.3) (72.9) (43.1) (17.9) (8.8) (5.0) (1.7) (0.3)
Other Accumulative Comprehensive Income/Loss (4.6) (8.4) (4.0) 5.4 (2.4) (1.4) (0.3) 20 K (4.8) 25 K 12 K 26 K 12 K 6 K 18 K 0.3 0.3 0.1 60 K 10 K 31 K (0.1) (1.7) (5.0) (1.8) 0 0 0
Total Equity 82.9 295.0 375.3 496.5 432.9 367.3 187.9 136.2 192.4 206.6 121.7 64.9 80.1 55.9 71.8 55.4 72.1 48.7 37.8 32.4 44.7 54.2 82.3 66.9 7.9 3.4 6.4 0.4
Total Liabilities and Equity 165.3 562.5 721.9 938.5 637.5 590.4 286.7 157.9 217.2 243.2 140.8 82.5 87.3 63.0 87.4 67.8 83.9 55.8 49.0 34.7 46.2 56.2 85.0 68.9 9.2 4.0 6.9 0.5
SHARES OUTSTANDING
Common Shares Outstanding 174.4 154.3 144.6 134.4 112.1 96.9 78.1 70.6 69.8 67.0 56.0 52.7 50.5 45.2 42.0 40.8 37.4 32.5 25.9 25.1 24.8 24.5 23.1 17.4 6.0 5.8 5.5 5.1